StockData
CorMedix Inc. logo

CorMedix Inc. (CRMD) stock

CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.67−0.15 (-3.11%)

Close on Nov 17, 2026Market cap $364.00MP/E –Yield –

CorMedix r&d expenses

Research and development expenses are spending on new products and technology.

CorMedix's R&D Expenses for the twelve months ending Jun 30, 2026 was $27.59M, up 241.1% year over year. For fiscal 2025 it was $19.33M, up 390.4% from the year before. Over ten years it grew 11.9% a year on average. The highest annual figure on record is $24.49M in fiscal 2017.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$19.33M+390.4%
FY2024Dec 31, 2024$3.94M-70.0%
FY2023Dec 31, 2023$13.16M+23.2%
FY2022Dec 31, 2022$10.68M-18.7%
FY2021Dec 31, 2021$13.13M-1.8%
FY2020Dec 31, 2020$13.38M+21.0%
FY2019Dec 31, 2019$11.05M-41.3%
FY2018Dec 31, 2018$18.82M-23.1%
FY2017Dec 31, 2017$24.49M+55.6%
FY2016Dec 31, 2016$15.74M+150.5%
FY2015Dec 31, 2015$6.28M+376.4%
FY2014Dec 31, 2014$1.32M+7.5%
FY2013Dec 31, 2013$1.23M+7.4%
FY2012Dec 31, 2012$1.14M-71.8%
FY2011Dec 31, 2011$4.06M-26.1%
FY2010Dec 31, 2010$5.49M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$6.68M+173.7%
Q1 FY2026Mar 31, 2026$7.21M+125.9%
Q4 FY2025Dec 31, 2025$8.60M+398.1%
Q3 FY2025Sep 30, 2025$5.10M+601.1%
Q2 FY2025Jun 30, 2025$2.44M+275.1%
Q1 FY2025Mar 31, 2025$3.19M+281.3%
Q4 FY2024Dec 31, 2024$1.73M-24.6%
Q3 FY2024Sep 30, 2024$727.12K-72.7%
Q2 FY2024Jun 30, 2024$650.99K-86.4%
Q1 FY2024Mar 31, 2024$837.45K-75.4%
Q4 FY2023Dec 31, 2023$2.29M-19.5%
Q3 FY2023Sep 30, 2023$2.66M+13.9%
Q2 FY2023Jun 30, 2023$4.79M+49.4%
Q1 FY2023Mar 31, 2023$3.41M+49.0%
Q4 FY2022Dec 31, 2022$2.84M-12.1%
Q3 FY2022Sep 30, 2022$2.34M-50.7%
Q2 FY2022Jun 30, 2022$3.21M+27.3%
Q1 FY2022Mar 31, 2022$2.29M-13.2%
Q4 FY2021Dec 31, 2021$3.24M+41.0%
Q3 FY2021Sep 30, 2021$4.74M+62.1%
Q2 FY2021Jun 30, 2021$2.52M-55.7%
Q1 FY2021Mar 31, 2021$2.64M+6.6%
Q4 FY2020Dec 31, 2020$2.29M-14.3%
Q3 FY2020Sep 30, 2020$2.93M+16.0%
Q2 FY2020Jun 30, 2020$5.69M+90.8%
Q1 FY2020Mar 31, 2020$2.47M-14.0%
Q4 FY2019Dec 31, 2019$2.68M-67.7%
Q3 FY2019Sep 30, 2019$2.52M-61.8%
Q2 FY2019Jun 30, 2019$2.98M-64.0%
Q1 FY2019Mar 31, 2019$2.87M-66.0%
Q3 FY2018Sep 30, 2018$8.29M+37.8%
Q2 FY2018Jun 30, 2018$6.60M+29.7%
Q1 FY2018Mar 31, 2018$8.28M+68.2%
Q4 FY2017Dec 31, 2017$8.46M+209671.1%
Q3 FY2017Sep 30, 2017$6.01M-12.1%
Q2 FY2017Jun 30, 2017$5.09M–
Q1 FY2017Mar 31, 2017$4.92M–
Q4 FY2016Dec 31, 2016$4.03K–
Q3 FY2016Sep 30, 2016$6.84M–

More CorMedix figures

See a number that looks wrong?